Abstract
A number of 46 out of a total of more than 200 recent patents in soft nanotechnology referring to applications of nanoemulsions for pharmaceutical and cosmetical formulations has been selected and reviewed. As key factors to maximize the efficiency of bioactive principles embedded within colloidal drug delivery systems are the nature and ratio of hydrophilic/lipophilic components, of surfactants/cosurfactants as emulsifiers, their mutual solubility and biocompatibility, the size and polydispersity of nanoparticles. The antioxidant and immunostimulative actions are discussed in relation to the specific therapeutic effects of galenical compositions used for preventing and/or treating various diseases.
Keywords: Nanoemulsions, microemulsions, solid lipid nanoparticles, antioxidant, immunostimulative activity
Recent Patents on Nanotechnology
Title: Pharmaceuticals and Cosmeceuticals Based on Soft Nanotechnology Techniques with Antioxidative, Immunostimulative and other Therapeutic Activities
Volume: 2 Issue: 2
Author(s): Aurelia Meghea
Affiliation:
Keywords: Nanoemulsions, microemulsions, solid lipid nanoparticles, antioxidant, immunostimulative activity
Abstract: A number of 46 out of a total of more than 200 recent patents in soft nanotechnology referring to applications of nanoemulsions for pharmaceutical and cosmetical formulations has been selected and reviewed. As key factors to maximize the efficiency of bioactive principles embedded within colloidal drug delivery systems are the nature and ratio of hydrophilic/lipophilic components, of surfactants/cosurfactants as emulsifiers, their mutual solubility and biocompatibility, the size and polydispersity of nanoparticles. The antioxidant and immunostimulative actions are discussed in relation to the specific therapeutic effects of galenical compositions used for preventing and/or treating various diseases.
Export Options
About this article
Cite this article as:
Meghea Aurelia, Pharmaceuticals and Cosmeceuticals Based on Soft Nanotechnology Techniques with Antioxidative, Immunostimulative and other Therapeutic Activities, Recent Patents on Nanotechnology 2008; 2 (2) . https://dx.doi.org/10.2174/187221008784534541
DOI https://dx.doi.org/10.2174/187221008784534541 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Disease State, Age, Sex, and Post-Mortem Time-Dependent Expression of Proteins in AD vs. Control Frontal Cortex Brain Samples
Current Alzheimer Research Trifluoroethanol-induced Activity and Structural Changes in Bos taurus Copper- and Zinc-containing Superoxide Dismutase
Protein & Peptide Letters Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels
Current Diabetes Reviews Cellular and Biochemical Actions of Melatonin which Protect Against Free Radicals: Role in Neurodegenerative Disorders
Current Neuropharmacology Patent Selections
Recent Patents on DNA & Gene Sequences Walking the Oxidative Stress Tightrope: A Perspective from the Naked Mole-Rat, the Longest-Living Rodent
Current Pharmaceutical Design The Biology of Neurotrophins, Signalling Pathways, and Functional Peptide Mimetics of Neurotrophins and their Receptors
CNS & Neurological Disorders - Drug Targets Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Targeting Exocytosis: Ins and Outs of the Modulation of Quantal Dopamine Release
CNS & Neurological Disorders - Drug Targets Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases
Current Protein & Peptide Science Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and Neuroinflammation
Current Alzheimer Research Oxidative Stress During Myocardial Ischaemia and Heart Failure
Current Pharmaceutical Design Aluminum Induced Immunoexcitotoxicity in Neurodevelopmental and Neurodegenerative Disorders
Current Inorganic Chemistry (Discontinued) Editorial (Thematic Issue: Ultrasonic Vocalizations in Rats: A Tool for the Investigation of Psychoactive Drugs and Neuropsychiatric Conditions)
Current Neuropharmacology The Many Faces of Glutathione Transferase Pi
Current Molecular Medicine Structure and Comparative Analysis of the Bovine Prion Gene Locus
Current Genomics Targeting New Pharmacological Approaches for Alzheimer’s Disease: Potential for Statins and Phosphodiesterase Inhibitors
CNS & Neurological Disorders - Drug Targets Coping with Stress During Aging: The Importance of a Resilient Brain
Current Neuropharmacology Transforming Growth Factor-β Signaling in Motor Neuron Diseases
Current Molecular Medicine